{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:39:46Z","timestamp":1759333186114},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T00:00:00Z","timestamp":1252540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00417-009-1184-5","type":"journal-article","created":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T06:01:13Z","timestamp":1252476073000},"page":"1707-1710","source":"Crossref","is-referenced-by-count":25,"title":["Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin\u00ae) for treatment of angoid streaks in pseudoxanthoma elasticum"],"prefix":"10.1007","volume":"247","author":[{"given":"Martin","family":"Ganssauge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Ulrich","family":"Bartz-Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Aisenbrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,10]]},"reference":[{"key":"1184_CR1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/IAE.0b013e31809ff5df","volume":"27","author":"P Bhatnagar","year":"2007","unstructured":"Bhatnagar P, Freund KB, Spaide RF, Klancnik JM Jr, Cooney MJ, Ho I, Fine HF, Yannuzzi LA (2007) Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina 27:897\u2013902","journal-title":"Retina"},{"key":"1184_CR2","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archopht.125.10.1422","volume":"125","author":"M Rinaldi","year":"2007","unstructured":"Rinaldi M, Dell'Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C (2007) Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks. Arch Ophthalmol 125:1422\u20131423","journal-title":"Arch Ophthalmol"},{"key":"1184_CR3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1600-0420.2006.00762.x","volume":"84","author":"A Teixeira","year":"2006","unstructured":"Teixeira A, Moraes N, Farah ME, Bonomo PP (2006) Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks. Acta Ophthalmol Scand 84:835\u2013836","journal-title":"Acta Ophthalmol Scand"},{"key":"1184_CR4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4103\/0301-4738.36482","volume":"55","author":"N Sachdev","year":"2007","unstructured":"Sachdev N, Vishwanathan K, Gupta V, Singh R, Gupta A (2007) Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks. Indian J Ophthalmol 55:457\u2013458","journal-title":"Indian J Ophthalmol"},{"key":"1184_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00347-006-1456-y","volume":"104","author":"A Lommatzsch","year":"2007","unstructured":"Lommatzsch A, Spital G, Trieschmann M, Pauleikhoff D (2007) Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks. Ophthalmologe 104:325\u2013328","journal-title":"Ophthalmologe"},{"key":"1184_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","volume":"246","author":"L Wu","year":"2008","unstructured":"Wu L, Martinez-Castellanos MA, Quiroz-Mercado H et al (2008) Twelve-month safety of intravitreal injections of bevacizumab (Avastin\u00ae): Results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 246:81\u201387","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1184_CR7","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.ophtha.2006.11.035","volume":"114","author":"SS Hayreh","year":"2007","unstructured":"Hayreh SS, Zimmerman MB (2007) Incipient nonarteritic anterior ischemic optic neuropathy. Ophthalmology 114:1763\u20131772","journal-title":"Ophthalmology"},{"key":"1184_CR8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00347-006-1354-3","volume":"130","author":"F Ziemssen","year":"2006","unstructured":"Ziemssen F, Bartz-Schmidt KU, Grisanti S (2006) (Neben)-Wirkungen der VEGF-inhibition. Ophthalmologe 130:484\u2013490","journal-title":"Ophthalmologe"},{"key":"1184_CR9","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archopht.125.11.1568","volume":"125","author":"NJ Newman","year":"2007","unstructured":"Newman NJ (2007) The ischemic optic neuropathy decompression trail. Arch Ophthalmol 125:1568\u20131570","journal-title":"Arch Ophthalmol"},{"key":"1184_CR10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00417-005-0102-8","volume":"244","author":"B Wilhelm","year":"2006","unstructured":"Wilhelm B, L\u00fcdtke H, Wilhelm H (2006) BRAION Study Group: Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (N-AION): A 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol 244:551\u2013558","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1184_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.preteyeres.2008.11.002","volume":"28","author":"SS Hayreh","year":"2009","unstructured":"Hayreh SS (2009) Ischemic optic neuropathy. Prog Retin Eye Res 28:34\u201362","journal-title":"Prog Retin Eye Res"},{"key":"1184_CR12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00417-008-0805-8","volume":"246","author":"SS Hayreh","year":"2008","unstructured":"Hayreh SS, Zimmerman MB (2008) Non-arteritic anterior ischemic: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 246:1029\u20131046","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1184_CR13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/WNO.0b013e31814b273d","volume":"27","author":"JL Bennett","year":"2007","unstructured":"Bennett JL, Thomas S, Olson JL, Mandava N (2007) Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol 27:238\u2013240","journal-title":"J Neuroophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1184-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-009-1184-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1184-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:40:49Z","timestamp":1559072449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-009-1184-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,10]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1007\/s00417-009-1184-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,10]]}}}